skip to Main Content

A New Strategy to Prevent the Most Aggressive Tumors from Generating Resistance to Chemotherapy

Newsfeed image, light gray text on dark gray background
One of the most frequent problems when treating cancer is that the tumors develop resistance to therapies; at that point, treatments cease to be effective at stopping tumor growth. This is especially relevant in patients with aggressive diseases such as pancreatic cancer or patients with metastases, who must often undergo frequent changes in treatment. {/subhead]

Now, a study led by the Spanish National Cancer Research Centre (CNIO) in collaboration with researchers from the Weill Cornell Medicine Center and Pfizer Inc. (U.S.), proposes a novel combined approach to avoiding pancreatic cancer resistance to chemotherapy, and thus treat these tumor cells effectively. The work is forthcoming in the journal Cancer Cell. Read more . . . 

Back To Top